Drug–drug interactions in italian patients with chronic hepatitis C treated with pangenotypic direct acting agents: Insights from a real-world study

Autor: Nicola Coppola, Gema Alvarez Nieto, Giovanni Di Perri, Candido Hernandez, Stefano Fagiuoli, Luca Degli Esposti, Valentina Perrone, Pierluigi Toniutto, Alessandra Mangia, Stefano Calabrese, Francesco Scaglione, Mario Pirisi

Publikováno v: International Journal of Environmental Research and Public Health
Volume 18
Issue 13
International Journal of Environmental Research and Public Health, Vol 18, Iss 7144, p 7144 (2021)

This Italian observational real-world study aims to assess in chronic hepatitis C virus (HCV) patients treated with pangenotypic direct acting agents (pDAAs) glecaprevir/pibrentasvir (GLE/PIB) or sofosbuvir/velpatasvir (SOF/VEL) the potential drug–

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccbf70661d47482fee57e0884c8226e9
http://hdl.handle.net/10281/353761